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Abstract
Our experience with the Sapien trans-apical aortic valve (Edwards Lifesciences Inc., Irvine, CA, USA) has been straightforward without per-
procedural mortality except in 1/16 consecutive cases who developed non-apical haemorrhage early after valve implantation. We describe the
case of an 84-year-old female carrying a very high operative risk (logistic EuroScore of 44%), who underwent a trans-apical stent-valve
implantation for severe and symptomatic aortic valve stenosis (23 mm). Due to massive blood loss, an emergency sternotomy and cannulation for
cardiopulmonary bypass resuscitation were necessary to treat (without success) an unusual and unexpected subaortic left ventricular free-wall
rupture that occurred fewminutes after the stent-valve positioning and implantation. To the best of our knowledge, this is the first described case
of a left ventricular free-wall rupture occurring after an otherwise non-complicated standard catheter-based aortic valve replacement.
# 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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The trans-apical aortic valve implantation (TA-AVI) is a valid
alternative to the standard aortic valve replacement for
patients requiring AVR, and carrying a high operative risk
(logistic EuroScore >20%): together with the transfemoral
approach (TF-AVI), the amount of stent-valve bio-prostheses
implanted worldwide is increasing constantly. Nevertheless, it
is well known that all new surgical procedures, approaches,
devices and technologies carry a risk of unexpected complica-
tions intrinsically related to the procedure itself: complica-
tions following TA/TF-AVI (valve migration/malpositioning,
vascular dissections and ruptures, embolisation, renal failure,
strokes and bleeding from the cardiac apex) have already been
described in the literature and, thanks to that, they are now
predictable and treatable [1—4]. On the other hand, the trans-
catheter procedures are still new and some rare complications
can still occur because of the very fragile patient’s tissues or
because of concomitant co-morbidities in the elderly and the
very-high-risk patients. In a series of 16 consecutive TA-AVI
with the Sapien device (Edwards Lifesciences Inc., Irvine, CA,
USA), we report case 15, an unexpected and unpredicted life-* Corresponding author. Address: Department of Cardio-Vascular Surgery,
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ventricle that occurred few minutes after the stent-valve
deployment, during an otherwise uncomplicated TA-AVI
procedure. To the best of our knowledge, a left ventricle
free-wall rupture during a catheter-based aortic valve
procedure has never been described before.2. Case report
An 84-year-old female suffering from symptomatic aortic
stenosis was scheduled for TA-AVI (15th from a series of 16
consecutive cases). Co-morbidities were severe respiratory
disease (oxygen therapy at home), peripheral vascular disease
(bilateral femoral and iliac artery stenosis/occlusion), pul-
monary hypertension (60 mmHg of systolic pulmonary pres-
sure), obesity, diabetes II and systemic hypertension. The
preoperative echocardiogram (ECG) showed a stenosis with
peak gradient of 70 mmHg, mean of 40 mmHg, surface area of
0.5 cm2 and a severe concentric left ventricular hypertrophy
with septal spur. The left ventricular function was preserved.
The calculated logistic EuroScore was 44% and the patient
accepted a TA-AVI procedure. A three-dimensional CTscan and
a coronary angiogram were performed to identify the land-
marks for the valve implantation and to calculate the
perspective of aortic valve plane for the C-arm fluoroscopy
pre-orientation (148 left and 108 cranial). The aortic annulusurgery. Published by Elsevier B.V. All rights reserved.
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Fig. 1. The preoperative cardiac CT scan showed an aortic valve annulus
diameter of 20 mm.
Fig. 2. Intraoperative images from the trans-oesophageal echocardiogram (A)
and from the C-arm fluoroscopy (B) confirming the perfect stent-valve posi-
tioning and deployment in the ideal landing zone.was heavily calcified andmeasured 20 mmdiameter; coronary
anomalies were not found (Fig. 1). The CTscan also showed an
unexpected lipomatosis of the inter-atrial septum and
confirmed the subaortic spur. Under general anaesthesia
and in the operative theatre, we performed the TA-AVI
procedure. We noted that trans-oesophageal echocardiogram
(TEE) confirmed an aortic valve annulus of 19.5 mm; guide-
wires/pigtail were inserted through a surgically exposed left
subclavian artery (occluded femoral axes); the tissues in
general and the cardiac apex in particular were very fragile (a
double purse-string suture was performed very carefully); and
we implanted a 23-mm Sapien valve (Edwards Lifesciences
Inc., Irvine, CA, USA) in the ideal landing zone (for a 19.5—
20 mm annulus, the oversize was 15%). During the procedure,
the patient’s vital signs and haemodynamics remained
unchanged. Fluoroscopy and TEE confirmed the absence of a
paravalvular leakage, a gradient of 6 mmHg and a patent
coronary ostia (Fig. 2A and B). Few minutes later, the patient
experienced a sudden severe hypotensionwith red fresh blood
coming from the mini-thoracotomy. After having immediately
established that the cardiac apex was not the source of the
bleeding, we performed a sternotomy in emergency following
a suspicionofascendingaorta rupture/dissection. Surprisingly,
the ascending aorta was not damaged and, once the
cardiopulmonary bypass (CPB) was established, we found a
massive bleeding from a 4-cm-long longitudinal tear in the
subaortic free wall of the left ventricle, just behind the left
atrial appendage. After suturing the lesion with large
pledgeted U-stitches, bleeding could be controlled; however,
weaning from CPB was unsuccessful.3. Discussion
Unexpected, unexplainable complications canoccur during
emerging surgical procedures. We describe a free-wall
ventricular rupture following TA-AVI. Traditionally, the fragi-
lity of the cardiac apex is the most important cause of surgical
bleeding during TA-AVI procedures, and it remains, despite alltentative efforts to prevent it (e.g., purse-string sutures,
reinforced crossing U-stitches and sheets removal under rapid
pacing), themost dreadful source ofmassiveblood loss related
to this approach [5,6]. Nevertheless, a new and unexpected
source of bleeding seems to be the left ventricle free-wall
rupture in the subaortic region, between the left descending
coronary artery and the circumflex artery, that we experi-
enced after the stent-valve deployment. A relatively small
aortic valve annulus (19.5—20 mm) with a severe subaortic
ventricular hypertrophy and spur, concomitant with very
fragile tissues in a small elderly female patient, can be the
predisposing factors at the origin of this unexpected problem;
in particular, we believe that patients with long-lasting history
of poor peripheral tissue oxygenation (e.g., chronic obstruc-
tive pulmonary disease (COPD)) or low cardiac output could
carry an increased tissue fragility and can be at risk for such a
complication. Moreover, the discrepancy between the aortic
annulus and the stent-valve size has to be taken in account as a
key factor; the traditional oversizing is around 10% and,
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reduce the stress against a fragile aortic wall with a little
residual elasticity or against a fragile subaortic ventricular
tissue. According to our experience, improvements in pre- and
intra-operative cardiac imaging for measurements and
assessment or a lower balloon inflation (oversize of 10—12%
maximum) during the valve deployment could be helpful in
prevention (in our series of 16patients themeanaortic annulus
was 22.37  1.54 mm and the mean stent-valve size was
24.58 1.55 mm with 9% oversizing, compared with 15%
oversizing for this patient). This outcome confirms the
importance of a CPB standby, and emphasises the role of
cardiac surgeons acting during any trans-catheter procedure
to guarantee emergency CPB re-animation and all possible
attempts to treat uncommon and unpredictable tricky
situations.
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